Compare IVDA & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVDA | BRTX |
|---|---|---|
| Founded | 2003 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Managed Health Care |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 3.1M |
| IPO Year | 2015 | 2015 |
| Metric | IVDA | BRTX |
|---|---|---|
| Price | $0.23 | $1.64 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $160.00 |
| AVG Volume (30 Days) | ★ 176.6K | 28.5K |
| Earning Date | 11-13-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.38 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,468,279.00 | $81,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $383.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 132.98 | N/A |
| 52 Week Low | $0.21 | $0.14 |
| 52 Week High | $1.52 | $34.00 |
| Indicator | IVDA | BRTX |
|---|---|---|
| Relative Strength Index (RSI) | 37.90 | 36.43 |
| Support Level | $0.22 | $1.28 |
| Resistance Level | $0.31 | $2.93 |
| Average True Range (ATR) | 0.02 | 0.18 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 18.32 | 31.37 |
Iveda Solutions Inc offers smart city technologies globally, offering AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products). Geographically, the company operates in USA and Taiwan, majority of its revenue is generated from Taiwan.
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.